| Quarter | Score |
|---|---|
| 2024-Q3 | 33.5 |
| 2024-Q4 | 30.9 |
| 2025-Q2 | 37.7 |
| 2025-Q3 | 61.5 |
| 2025-Q4 | 38.6 |
| 2026-Q2 | 62.0 |
Solid consensus with smart money net adding at reasonable prices
Trading 74.3% below funds' estimated purchase price
1 of 18 tracked funds hold BIOA. Avg conviction: 0.0%. Net adding. First tracked at $24.51 (current -74.3% vs tracked).
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Citadel Advisors | 0.0% | Reduce |